Elanco Animal Health Incorporated
ELAN
$24.42
$0.451.88%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.23% | 14.92% | 12.16% | 10.39% | 4.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.23% | 14.92% | 12.16% | 10.39% | 4.81% |
| Cost of Revenue | 7.95% | 15.13% | 10.78% | 7.72% | 6.67% |
| Gross Profit | 11.92% | 14.77% | 13.49% | 12.83% | 3.48% |
| SG&A Expenses | 12.25% | 11.73% | 12.59% | 8.67% | 12.99% |
| Depreciation & Amortization | 2.21% | 7.81% | 6.92% | 5.26% | 3.82% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.13% | 12.13% | 11.13% | 7.25% | 8.14% |
| Operating Income | 38.82% | 39.67% | 85.71% | 640.00% | -26.09% |
| Income Before Tax | 124.00% | 45.00% | -407.84% | -108.94% | 178.13% |
| Income Tax Expenses | -85.71% | 528.57% | 139.53% | -108.21% | -22.22% |
| Earnings from Continuing Operations | 390.91% | -14.93% | -3,350.00% | -109.34% | 122.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 390.91% | -14.93% | -3,350.00% | -109.34% | 122.00% |
| EBIT | 38.82% | 39.67% | 85.71% | 640.00% | -26.09% |
| EBITDA | 15.04% | 22.71% | 15.48% | 25.81% | -7.87% |
| EPS Basic | 386.94% | -15.37% | -3,328.40% | -109.29% | 121.94% |
| Normalized Basic EPS | 148.62% | 48.45% | -2.20% | 61.06% | -46.13% |
| EPS Diluted | 440.50% | -15.38% | -2,758.67% | -109.59% | 119.76% |
| Normalized Diluted EPS | 147.08% | 47.22% | -2.20% | 60.82% | -46.46% |
| Average Basic Shares Outstanding | 0.58% | 0.53% | 0.51% | 0.51% | 0.49% |
| Average Diluted Shares Outstanding | 1.16% | 1.38% | 0.51% | -0.18% | 1.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |